ODDB.org: Open Drug Database

GlaxoSmithKline AG - Rotarix, Suspension zum Einnehmen

Swissmedic Registration	60150	Sequence	01
Product name	Rotarix	Description	Suspension zum Einnehmen
ATC-Classification	J07BH01	ATC-Description	Rota Virus, Live Attenuated
Introduction of Sequence	13.05.2009

Composition

Vaccinum attenuatum: rotavirus humanus vivus attenuatum (Stamm: RIX4414) min 1 Mio U., saccharum 1073 mg, dinatrii adipas, Dulbecco's modified eagle medium cum phenylalaninum 15 µg et glucosum 0.01 mg, aqua ad iniectabile q.s. ad suspensionem pro 1.5 ml corresp. natrium 32 mg.

Packungsbestandteile

Galenic Form

Suspension (oral)

Excipiens

Active Agent	Dose	additional_information
Rotavirus Humanus Vivus Attenuatum (Stamm: Rix4414) Min	1Mio U. / 1.5ml	Vaccinum attenuatum

BAG: Active Agent	Dose
Rotavirus Humanus (Stamm: Rix4414)	1 Mio U

Inactive agents	Dose
Dinatrii Adipas
Dulbecco's Modified Eagle Medium cum Phenylalaninum	15µg / 1.5ml
Glucose	0.01mg / 1.5ml
Saccharum	1073mg / 1.5ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001				B		Yes
004		39.36	59.20	B	SL	No
006	10	393.60	444.50	B	SL	No

2026	©ywesee GmbH